Fueling the engine and releasing the break: combinational therapy of cancer vaccines and immune checkpoint inhibitors

Immune checkpoint inhibitors are increasingly drawing much attention in the therapeutic development for cancer treatment. However, many cancer patients do not respond to treatments with immune checkpoint inhibitors, partly because of the lack of tumor-infiltrating effector T cells. Cancer vaccines m...

Descripción completa

Detalles Bibliográficos
Autores principales: Kleponis, Jennifer, Skelton, Richard, Zheng, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Anti-Cancer Association 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607816/
https://www.ncbi.nlm.nih.gov/pubmed/26487965
http://dx.doi.org/10.7497/j.issn.2095-3941.2015.0046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607816/
https://www.ncbi.nlm.nih.gov/pubmed/26487965
http://dx.doi.org/10.7497/j.issn.2095-3941.2015.0046

Ejemplares similares